FindMyKOL

Top experts by indication / Ophthalmology

Most active experts in Glaucoma

2026 edition, data as of October 26, 2026

380 key opinion leaders in the directory are tagged to Glaucoma. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.

Most registered trials

Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 75 of the 380 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.

#Experttrials
1George SpaethWills Eye Hospital, PA10 trials
2Nathan CongdonMD7 trials
3William StewartCleveland Clinic, OH7 trials
4Marlene MosterSouth Florida Eye Health, FL7 trials
5William StewartWY6 trials
6Jeremy KeenanUniversity of California, San Francisco, CA6 trials
7Joel SchumanWills Eye Hospital, PA6 trials
8Robert WeinrebUniversity of California, San Diego, CA5 trials
9Paula Newman-CaseyUniversity of Michigan, MI4 trials
10David FriedmanMA4 trials
11Iqbal AhmedUT4 trials
12Mona Harissi-DagherMA4 trials
13Leon HerndonDuke University Eye Center, NC4 trials
14Felipe MedeirosUniversity of Miami Miller School of Medicine, FL4 trials
15Louis CantorIndiana University School of Medicine, IN4 trials
16Harry QuigleyJohns Hopkins University School of Medicine, MD4 trials
17Donald BudenzUniversity of Miami Health System, FL4 trials
18Jeffrey LiebmannColumbia University Vagelos College of Physicians and Surgeons, NY4 trials
19Barbara WirostkoUT3 trials
20Jeffrey HendererPA3 trials
21Peter NetlandEastern Virginia Medical School, VA3 trials
22Christopher GirkinUniversity of California, San Diego, CA3 trials
23David WirtaEye Research Foundation, CA3 trials
24Sayoko MoroiThe Ohio State University, OH3 trials
25Nathan RadcliffeIcahn School of Medicine at Mount Sinai, NY3 trials

Most cited

Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 30 of the 380 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.

#Expertcitations
1Robert WeinrebUniversity of California, San Diego, CA71,138 citations
2Harry QuigleyJohns Hopkins University School of Medicine, MD65,146 citations
3Joel SchumanWills Eye Hospital, PA53,124 citations
4William StewartCleveland Clinic, OH30,760 citations
5Louis PasqualeIcahn School of Medicine at Mount Sinai, NY28,455 citations
6Felipe MedeirosUniversity of Miami Miller School of Medicine, FL28,178 citations
7Donald BudenzUniversity of Miami Health System, FL26,811 citations
8Jeffrey LiebmannColumbia University Vagelos College of Physicians and Surgeons, NY23,949 citations
9Julia HallerWills Eye Hospital, PA22,085 citations
10Pradeep RamuluJohns Hopkins University School of Medicine, MD14,186 citations
11Christopher GirkinUniversity of California, San Diego, CA14,176 citations
12George SpaethWills Eye Hospital, PA13,177 citations
13Steven GeddeBascom Palmer Eye Institute, FL11,184 citations
14Richard ParrishBascom Palmer Eye Institute, FL11,097 citations
15Jeremy KeenanUniversity of California, San Francisco, CA9,819 citations
16Dale HeuerMedical College of Wisconsin, WI7,816 citations
17Sayoko MoroiThe Ohio State University, OH7,763 citations
18Louis CantorIndiana University School of Medicine, IN7,667 citations
19Peter NetlandEastern Virginia Medical School, VA6,811 citations
20Steven MansbergerLegacy Health, OR5,418 citations
21Paula Newman-CaseyUniversity of Michigan, MI3,418 citations
22Nathan RadcliffeIcahn School of Medicine at Mount Sinai, NY2,726 citations
23Karen JoosVanderbilt University Medical Center, TN2,717 citations
24Jeffrey HendererPA2,327 citations
25Osamah SaeediUniversity of Maryland School of Medicine, MD2,265 citations

Most NIH awards

NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 23 of the 380 people tagged to this indication have at least 2 registered trials in it and this count on record; the 23 highest are listed. Source: NIH RePORTER.

#Expertawards
1Jeremy KeenanUniversity of California, San Francisco, CA12 awards
2David FriedmanMA9 awards
3Robert WeinrebUniversity of California, San Diego, CA9 awards
4Richard ParrishBascom Palmer Eye Institute, FL7 awards
5Harry QuigleyJohns Hopkins University School of Medicine, MD7 awards
6Paula Newman-CaseyUniversity of Michigan, MI6 awards
7Sayoko MoroiThe Ohio State University, OH5 awards
8George SpaethWills Eye Hospital, PA4 awards
9Steven MansbergerLegacy Health, OR4 awards
10Anthony RealiniWest Virginia University School of Medicine, WV4 awards
11Pradeep RamuluJohns Hopkins University School of Medicine, MD4 awards
12Osamah SaeediUniversity of Maryland School of Medicine, MD4 awards
13Louis PasqualeIcahn School of Medicine at Mount Sinai, NY3 awards
14Nathan CongdonMD2 awards
15Peter NetlandEastern Virginia Medical School, VA2 awards
16Felipe MedeirosUniversity of Miami Miller School of Medicine, FL2 awards
17Karen JoosVanderbilt University Medical Center, TN2 awards
18Julia HallerWills Eye Hospital, PA2 awards
19Donald BudenzUniversity of Miami Health System, FL2 awards
20Christopher GirkinUniversity of California, San Diego, CA1 award
21Joel SchumanWills Eye Hospital, PA1 award
22Jeffrey LiebmannColumbia University Vagelos College of Physicians and Surgeons, NY1 award
23Mark LatinaSpecialty Eye Consultants, MA1 award

Most congress contributions

Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 1 of the 380 people tagged to this indication have at least 2 registered trials in it and this count on record; the 1 highest are listed. Source: Congress abstracts, DOI-verified.

#Expertcontributions
1Robert WeinrebUniversity of California, San Diego, CA1 contribution

Emerging

13 of the 380 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.

Baseer AhmadMedical College of Wisconsin, WI
Robert BhisitkulUniversity of California, San Francisco, CA
Michele BloomerUniversity of California, San Francisco, CA
Nikhil BommakantiPA
Shu FengUniversity of Washington, WA
Tara McCannelUniversity of California, Los Angeles, CA
Angela OhUniversity of California, Los Angeles, CA
Andrew PouwUniversity of Iowa, IA
Michael ProWills Eye Hospital, PA
Rithambara RamachandranMI
Ronald SchacharCA
Ramin SchadluAZ
Parisa TaravatiUniversity of Washington, WA

How these tables are computed

The cohort is every profile in the directory tagged to Glaucoma, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.

Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.

The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.

What is deliberately absent

Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.

Filter, sort and open every Glaucoma profile in the directory